These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28189783)

  • 1. Hormonally up-regulated neu-associated kinase: A novel target for breast cancer progression.
    Zambrano JN; Neely BA; Yeh ES
    Pharmacol Res; 2017 May; 119():188-194. PubMed ID: 28189783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hunk is required for HER2/neu-induced mammary tumorigenesis.
    Yeh ES; Yang TW; Jung JJ; Gardner HP; Cardiff RD; Chodosh LA
    J Clin Invest; 2011 Mar; 121(3):866-79. PubMed ID: 21393859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of cell survival by HUNK mediates breast cancer resistance to HER2 inhibitors.
    Yeh ES; Abt MA; Hill EG
    Breast Cancer Res Treat; 2015 Jan; 149(1):91-8. PubMed ID: 25515931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of a potent and selective HUNK inhibitor for treatment of HER2+ breast cancer.
    Dilday T; Abt M; Ramos-SolĂ­s N; Dayal N; Larocque E; Oblak AL; Sintim HO; Yeh ES
    Cell Chem Biol; 2024 May; 31(5):989-999.e7. PubMed ID: 38307028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Staurosporine, an inhibitor of hormonally up-regulated neu-associated kinase.
    Zambrano JN; Williams CJ; Williams CB; Hedgepeth L; Burger P; Dilday T; Eblen ST; Armeson K; Hill EG; Yeh ES
    Oncotarget; 2018 Nov; 9(89):35962-35973. PubMed ID: 30542510
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Ramos-Solis N; Dilday T; Kritikos AE; Yeh ES
    Biomedicines; 2022 Nov; 10(12):. PubMed ID: 36551828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarker-guided sequential targeted therapies to overcome therapy resistance in rapidly evolving highly aggressive mammary tumors.
    Sahin O; Wang Q; Brady SW; Ellis K; Wang H; Chang CC; Zhang Q; Priya P; Zhu R; Wong ST; Landis MD; Muller WJ; Esteva FJ; Chang J; Yu D
    Cell Res; 2014 May; 24(5):542-59. PubMed ID: 24675532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Snf1-related kinase, Hunk, is essential for mammary tumor metastasis.
    Wertheim GB; Yang TW; Pan TC; Ramne A; Liu Z; Gardner HP; Dugan KD; Kristel P; Kreike B; van de Vijver MJ; Cardiff RD; Reynolds C; Chodosh LA
    Proc Natl Acad Sci U S A; 2009 Sep; 106(37):15855-60. PubMed ID: 19717424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HUNK phosphorylates EGFR to regulate breast cancer metastasis.
    Williams CB; Phelps-Polirer K; Dingle IP; Williams CJ; Rhett MJ; Eblen ST; Armeson K; Hill EG; Yeh ES
    Oncogene; 2020 Jan; 39(5):1112-1124. PubMed ID: 31597954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-Targeting of JNK and HUNK in Resistant HER2-Positive Breast Cancer.
    Phelps-Polirer K; Abt MA; Smith D; Yeh ES
    PLoS One; 2016; 11(4):e0153025. PubMed ID: 27045589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HUNK suppresses metastasis of basal type breast cancers by disrupting the interaction between PP2A and cofilin-1.
    Quintela-Fandino M; Arpaia E; Brenner D; Goh T; Yeung FA; Blaser H; Alexandrova R; Lind EF; Tusche MW; Wakeham A; Ohashi PS; Mak TW
    Proc Natl Acad Sci U S A; 2010 Feb; 107(6):2622-7. PubMed ID: 20133759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of interaction between ErbB2 and insulin receptor substrate signaling in breast cancer.
    Farabaugh SM; Chan BT; Cui X; Dearth RK; Lee AV
    Cell Commun Signal; 2016 Oct; 14(1):25. PubMed ID: 27765041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apigenin induces apoptosis through proteasomal degradation of HER2/neu in HER2/neu-overexpressing breast cancer cells via the phosphatidylinositol 3-kinase/Akt-dependent pathway.
    Way TD; Kao MC; Lin JK
    J Biol Chem; 2004 Feb; 279(6):4479-89. PubMed ID: 14602723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of LKB1 expression reduces the latency of ErbB2-mediated mammary gland tumorigenesis, promoting changes in metabolic pathways.
    Andrade-Vieira R; Xu Z; Colp P; Marignani PA
    PLoS One; 2013; 8(2):e56567. PubMed ID: 23451056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased erbB3 promotes erbB2/neu-driven mammary tumor proliferation and co-targeting of erbB2/erbB3 receptors exhibits potent inhibitory effects on breast cancer cells.
    Lyu H; Huang J; Edgerton SM; Thor AD; He Z; Liu B
    Int J Clin Exp Pathol; 2015; 8(6):6143-56. PubMed ID: 26261492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Generation and comparison of two genetically engineered mouse models of ErbB2/Neu positive-PTEN deficient breast cancer].
    Wang QF; Ding H; Liu BR; Zhang K
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2014 Jul; 43(4):427-33. PubMed ID: 25187457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Taspase1 cleaves MLL1 to activate cyclin E for HER2/neu breast tumorigenesis.
    Dong Y; Van Tine BA; Oyama T; Wang PI; Cheng EH; Hsieh JJ
    Cell Res; 2014 Nov; 24(11):1354-66. PubMed ID: 25267403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental role of the SNF1-related kinase Hunk in pregnancy-induced changes in the mammary gland.
    Gardner HP; Belka GK; Wertheim GB; Hartman JL; Ha SI; Gimotty PA; Marquis ST; Chodosh LA
    Development; 2000 Oct; 127(20):4493-509. PubMed ID: 11003847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor tyrosine kinase ERBB4 mediates acquired resistance to ERBB2 inhibitors in breast cancer cells.
    Canfield K; Li J; Wilkins OM; Morrison MM; Ung M; Wells W; Williams CR; Liby KT; Vullhorst D; Buonanno A; Hu H; Schiff R; Cook RS; Kurokawa M
    Cell Cycle; 2015; 14(4):648-55. PubMed ID: 25590338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hunk negatively regulates c-myc to promote Akt-mediated cell survival and mammary tumorigenesis induced by loss of Pten.
    Yeh ES; Belka GK; Vernon AE; Chen CC; Jung JJ; Chodosh LA
    Proc Natl Acad Sci U S A; 2013 Apr; 110(15):6103-8. PubMed ID: 23520049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.